VYXEOS

VYXEOS is an intravenous (IV) chemotherapy used for the treatment of adults and pediatric patients 1 year and older with certain types of newly-diagnosed secondary acute myeloid leukemia (sAML): therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)... Find information on VYXEOS® (daunorubicin and cytarabine), a treatment for adults for two types of newly-diagnosed AML, t-AML and AML-MRC. See Safety Info Warning about not substituting with other daunorubicin and/or cytarabine-containing products.